Mark Albers, MD
Enriched profileAssociate Professor of Neurology, Harvard Medical School; Associate Neurologist, Massachusetts General Hospital · Massachusetts General Hospital
Mark Albers is Associate Professor of Neurology, Harvard Medical School; Associate Neurologist, Massachusetts General Hospital at Massachusetts General Hospital. OpenAlex indexes 95 publications with 8,762 citations (h-index 40); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Mark Albers, MD PHD, is Associate Professor of Neurology, Harvard Medical School at Massachusetts General Hospital. The public record shows 95 publications with 8,762 citations (h-index 40), centered on Olfactory and Sensory Function Studies, Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 1 companies, 9 NIH-funded awards (2009–2026).
- Most recent indexed publication: 2026 · medRxiv
- Top research focus: Olfactory and Sensory Function Studies
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 18 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 50.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD
Sponsor: Massachusetts General Hospital
- Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Trial
Sponsor: Massachusetts General Hospital
- Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
Sponsor: Massachusetts General Hospital
Industry payments
Updated 18 Oct 2026
1 company reported payments to CMS in program years 2024–2024. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202415 payments$15,186openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Cholinesterase Inhibitor64.6%Galantamine Er59%Rivastigmine30%Galantamine Hbr7%Donepezil Hcl5%Part D<11 patientsN-methyl-D-aspartate Receptor Antagonist19.7%Memantine Hcl85%Memantine Hcl Er15%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
9 NIH research awards on record, funded 2009–2026 per NIH RePORTER. The latest:
- Defining the pathogenic relationship of TDP-43 inclusions and cytoplasmic double stranded RNA in AD and FTD
Harvard Medical School
FY2026$821,162R01AG078377 - Harnessing Diverse Bioinformatic Approaches To Repurpose Drugs For Alzheimers Disease And Related Dementias
Massachusetts General Hospital
FY2026$759,915R01AG058063 - Harnessing Diverse Bioinformatic Approaches To Repurpose Drugs For Alzheimers Disease And Related Dementias
Massachusetts General Hospital
FY2026$115,560R01AG058063
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- TYK2 mediates neuroinflammation in Alzheimer's disease brains with TDP-43 pathology.
Nature communications
Article2026 - Blocking RAN translation without altering repeat RNAs rescues C9ORF72-related ALS and FTD phenotypes.
Science (New York, N.Y.)
Article2026
Most-cited works
by citation count (OpenAlex)- 01A mammalian protein targeted by G1-arresting rapamycin–receptor complexArticle2,046 citations1994
- 02Tau positron emission tomographic imaging in aging and early A lzheimer diseaseArticle983 citations2015
- 03At the interface of sensory and motor dysfunctions and Alzheimer's diseaseArticle586 citations2014
- 04
- 05COVID-19 and the Chemical Senses: Supporting Players Take Center StageArticle341 citations2020
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗
- PhD in Organic Chemistry
Harvard University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗
Editorial & leadership roles
journal and society appointments- Member
Translational Neuroscience Committee, American Academy of Neurology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗
Secondary affiliations
appointments beyond the home institution- Associate Director
Massachusetts Center for Alzheimer's Therapeutic Science
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗ - Member
Harvard Program in Therapeutic Science
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dibs.duke.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fishersisland.net ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
James Januzzi, MD
Massachusetts General Hospital
Maurizio Fava, MD
Massachusetts General Hospital
Steven Greenberg, MD
Massachusetts General Hospital
Andrew Zhu, MD, PhD
Massachusetts General Hospital
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida Health